Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 10/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 8/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30755347 | 1.00 | FFAR1 (0.47) | FFAR1FFAR4SLC6A4HTR2AKCNH2 | |
| SCHEMBL25974302 | 0.83 | FFAR1 (0.46) | FFAR1FFAR4SLC6A4HTR2AKCNH2 | |
| SCHEMBL546111 | 0.82 | TDP1 (0.38) | KCNN4TDP1 | |
| SCHEMBL6832641 | 0.80 | FFAR1 (0.49) | FFAR1FFAR4SLC6A4HTR2AKCNH2 | |
| SCHEMBL13069269 | 0.80 | FFAR1 (0.49) | FFAR1FFAR4SLC6A4HTR2AKCNH2 | |
| SCHEMBL10111073 | 0.80 | TSHR (0.51) | TSHRSMN1; SMN2GAATDP1 | |
| SCHEMBL394047 | 0.79 | FFAR1 (0.46) | FFAR1FFAR4SLC6A4GAA | |
| SCHEMBL29385804 | 0.79 | FFAR1 (0.46) | FFAR1FFAR4SLC6A4GAA | |
| SCHEMBL9901812 | 0.78 | GAA (0.41) | PTPN1TSHRSMN1; SMN2GAATDP1 | |
| SCHEMBL2475470 | 0.78 | MEN1 (0.48) | FFAR1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034123-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CEDILLA THERAPEUTICS INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-20210355110-A1 | THYROID HORMONE RECEPTOR AGONISTS | InventisBio Co., Ltd. (CN) | 2021-11-18 | — | — | US | disclosed |
| CN-101610675-A | Chemical compounds quinoline derivant and they purposes as agricultural chemicals | SYNGENTA PARTICIPATIONS AG (CH) | 2009-12-23 | — | — | CN | disclosed |
| WO-2008121602-A1 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-10-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034123-A1 | CDK2 INHIBITORS AND METHODS OF USING THE SAME | CDK2, CDK1, CDK20 | FFAR1 3730/4885FFAR4 4178/4885SLC6A4 4399/4885 |
| US-20210355110-A1 | THYROID HORMONE RECEPTOR AGONISTS | TSHR, THRA, TRHR | FFAR1 17/4885FFAR4 16/4885SLC6A4 2014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.